生物
遗传建筑学
肝硬化
计算生物学
遗传学
进化生物学
生物信息学
表型
基因
内科学
医学
作者
Jonas Ghouse,Garðar Sveinbjörnsson,Marijana Vujković,Anne-Sofie Seidelin,Helene Gellert‐Kristensen,Gustav Ahlberg,Vinicius Tragante,S A Rand,Joseph Brancale,Sílvia Vilarinho,Pia R. Lundegaard,Erik Sørensen,Christian Erikstrup,Mie Topholm Bruun,Bitten Aagaard Jensen,Søren Brunak,Karina Banasik,Henrik Ullum,Niek Verweij,Luca A. Lotta
出处
期刊:Nature Genetics
[Springer Nature]
日期:2024-04-17
卷期号:56 (5): 827-837
被引量:24
标识
DOI:10.1038/s41588-024-01720-y
摘要
We report a multi-ancestry genome-wide association study on liver cirrhosis and its associated endophenotypes, alanine aminotransferase (ALT) and γ-glutamyl transferase. Using data from 12 cohorts, including 18,265 cases with cirrhosis, 1,782,047 controls, up to 1 million individuals with liver function tests and a validation cohort of 21,689 cases and 617,729 controls, we identify and validate 14 risk associations for cirrhosis. Many variants are located near genes involved in hepatic lipid metabolism. One of these, PNPLA3 p.Ile148Met, interacts with alcohol intake, obesity and diabetes on the risk of cirrhosis and hepatocellular carcinoma (HCC). We develop a polygenic risk score that associates with the progression from cirrhosis to HCC. By focusing on prioritized genes from common variant analyses, we find that rare coding variants in GPAM associate with lower ALT, supporting GPAM as a potential target for therapeutic inhibition. In conclusion, this study provides insights into the genetic underpinnings of cirrhosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI